The Inspirational Quest to Eradicate Cancer

The world-renowned Thoracic Oncologist, Dr. Gerold Bepler, joined I Don’t Care’s Kevin Stevenson for a conversation that was no less than inspirational. Dr. Bepler, President and CEO of the Karmanos Cancer Institute, has a mission; to eradicate cancer. It’s more than a dream for Dr. Bepler; he believes it will be a reality one day.

Dr. Bepler arrived from Germany to the United States in 1983. Following a post-doctoral fellowship at the National Cancer Institute, the starting point for his journey into lung cancer research. This career path took Dr. Bepler through many stops along the way, and in 2010 he joined the Karmanos Cancer Institute.

The mission to eradicate cancer got a boost in 1971 with the National Cancer Act, and Dr. Bepler said there’s tremendous progress towards this goal since that point. “People now diagnosed with cancer have hope,” Dr. Bepler said. “And many of them get cured of the disease and have a good quality of life. That all wouldn’t have been possible without the National Cancer Act.”

Much of the progress made to eradicating cancer at the Karmanos Cancer Institute owes a debt of gratitude to that 50-year-old law for providing necessary funding that makes such research possible.

“The Karmanos Cancer Institute became one of the NCI designated cancer centers,” Dr. Bepler said. “Very quickly, the National Cancer Institute realized just having one cancer institute in Bethesda, Maryland alone wouldn’t be able to achieve that high goal of eradicating cancer. This network established cancer centers throughout the United States.” What started as a couple of centers in the 1970s is now more than 50 comprehensive cancer centers.

The world now possesses many drugs and treatments to treat cancer through the dedication and research of institutes like the Karmanos Center. And some research led to treatments for other diseases. Dr. Bepler mentioned the Karmanos Center developed three of the first FDA-approved AIDS drugs.

More Like This Story:

The Rising Tide of Food Allergens

From an Idea to Billion Dollar Company: How a Doctor Lobbied DC for HSAs

Follow us on social media for the latest updates in B2B!

Image

Latest

IC-SAT100
Meet IC-SAT100, a Satellite PTT Radio Built for the World’s Most Demanding Environments
February 5, 2026

Let’s have a look at Icom’s IC-SAT100, a satellite Push-To-Talk radio designed for moments when ordinary communication just isn’t an option. Powered by the Iridium satellite network, this rugged handheld delivers instant one-to-many communication at the push of a button—no cell towers or ground infrastructure required. Built to thrive in harsh environments, it’s waterproof,…

Read More
IP110H
From Hospitals to Warehouses, the IP110H Keeps Your Team in Sync
February 5, 2026

Icom’s IP110H is a compact, license-free WLAN radio built to keep teams talking—clearly and instantly—over an existing wireless network. Designed for environments like hospitals, hotels, warehouses, and tunnels, it delivers real-time, full-duplex voice using Icom’s advanced IP radio system. From Bluetooth capability to USB-C charging and a sleek, pocket-friendly design, the IP110H feels modern,…

Read More
IP501H
The IP501H Brings Effortless, Wide-Area Communication to Your Team
February 4, 2026

Meet Icom’s IP501H, a cellular two-way radio built for instant wide-area communication over LTE (4G) and 3G networks. It works just like a traditional radio—supporting individual, group, and all-call conversations—without the need for repeaters or a dedicated IP network. With everything included in the box, the IP501H is designed for quick setup and fast…

Read More
IP730D
One Radio, Three Networks, Seamless Coverage: Meet the IP730D
February 4, 2026

Icom’s IP730D is a true game-changer in professional communications, blending LTE, IDAS, and analog networks into one powerful hybrid radio. Designed for flexibility and confidence in the field, it uses dual PTT buttons to let users transmit and receive across networks seamlessly—delivering reliable, wide-area coverage wherever it’s needed. From the moment it comes out of…

Read More